{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:07:38Z","timestamp":1786975658655,"version":"build-2736575974"},"reference-count":21,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Foot ulcers are a common and feared complication for people with diabetes because 20% of foot ulcers become infected and lead to a lower extremity amputation.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the effect of daily foot care using chlorhexidine wipes vs soap-and-water wipes for 1 year on the risk of developing new foot complications in veterans with diabetes.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This double-blind, placebo-controlled, phase 2b randomized clinical trial was conducted at the Baltimore Veterans Affairs (VA) Medical Center between January 2019 to January 2023. Veterans were eligible if they had a diabetes diagnosis, were at high risk for diabetic foot complications, were ambulatory, had both feet, and did not have a current foot infection. Participants were randomly assigned 1:1 to receive either soap-and-water wipes (control group) or 2% chlorhexidine wipes (chlorhexidine group). Intention-to-treat data analysis was conducted from October 5, 2023, to April 24, 2024.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Daily use of a 2% chlorhexidine wipe or a soap-and-water wipe on the feet for 1 year. Wipes were nearly identical in color, size, shape, thickness, feel, and scent. Both chlorhexidine and control groups received the same lotion for application on the feet after wipe use and education on foot self-care.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was time in days from randomization to new foot complication, including chronic foot ulcer, foot infection, or foot amputation.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 175 participants (170 males [97%]; mean [SD] age at enrollment, 68 [9] years; 1 Asian [1%], 117 Black or African American [67%], 53 White [30%] individuals) were randomly assigned to the chlorhexidine group (n\u2009=\u200988) or the control group (n\u2009=\u200987). Twelve participants (14%) in the chlorhexidine group and 14 participants (16%) in the control group developed a new foot complication within 1 year. Median (IQR) time from randomization to development of a new foot complication was 232 (115-315) days. The reduction in hazard of new foot complications in the chlorhexidine group compared with the control group was not significant (hazard ratio, 0.83; 95% CI, 0.39-1.80). The intervention was well tolerated, with 145 participants (83%) continuing it over the study period. Sixty adverse events occurred, but none was related to the study products or procedures.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This randomized clinical trial found that daily use of chlorhexidine wipes for foot washing for 1 year did not lead to a significant reduction in the risk of new foot complications compared with daily use of soap-and-water wipes. The intervention was well tolerated, and the trial provides important lessons for future studies on diabetic foot ulcer prevention.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT03503370<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.60087","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:07:45Z","timestamp":1739876865000},"page":"e2460087","source":"Crossref","is-referenced-by-count":8,"title":["Chlorhexidine vs Routine Foot Washing to Prevent Diabetic Foot Ulcers"],"prefix":"10.1001","volume":"8","author":[{"given":"Alison D.","family":"Lydecker","sequence":"first","affiliation":[{"name":"Baltimore Veterans Affairs (VA) Medical Center, VA Maryland Health Care System, Baltimore"},{"name":"Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Baltimore Veterans Affairs (VA) Medical Center, VA Maryland Health Care System, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen L.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Baltimore Veterans Affairs (VA) Medical Center, VA Maryland Health Care System, Baltimore"},{"name":"Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kristie","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore"},{"name":"Department of Pathology, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton H.","family":"Brown","sequence":"additional","affiliation":[{"name":"Baltimore Veterans Affairs (VA) Medical Center, VA Maryland Health Care System, Baltimore"},{"name":"Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Petruccelli","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Terrin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Claire","family":"Roghmann","sequence":"additional","affiliation":[{"name":"Baltimore Veterans Affairs (VA) Medical Center, VA Maryland Health Care System, Baltimore"},{"name":"Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"issue":"24","key":"zoi241678r3","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence.","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi241678r4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2337\/diacare.13.5.513","article-title":"Pathways to diabetic limb amputation: basis for prevention.","volume":"13","author":"Pecoraro","year":"1990","journal-title":"Diabetes Care"},{"issue":"6098","key":"zoi241678r5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.1225152","article-title":"Compartmentalized control of skin immunity by resident commensals.","volume":"337","author":"Naik","year":"2012","journal-title":"Science"},{"issue":"12","key":"zoi241678r6","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/nm.2062","article-title":"Commensal bacteria regulate toll-like receptor 3-dependent inflammation after skin injury.","volume":"15","author":"Lai","year":"2009","journal-title":"Nat Med"},{"issue":"4","key":"zoi241678r7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrmicro2537","article-title":"The skin microbiome.","volume":"9","author":"Grice","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"zoi241678r8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-1-4614-0106-3","article-title":"Interaction of the microbiome with the innate immune response in chronic wounds.","volume":"946","author":"Grice","year":"2012","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"zoi241678r9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/sj.jid.5700701","article-title":"Inflammation in wound repair: molecular and cellular mechanisms.","volume":"127","author":"Eming","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"7","key":"zoi241678r10","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/infdis\/jit005","article-title":"Quantitation and composition of cutaneous microbiota in diabetic and nondiabetic men.","volume":"207","author":"Redel","year":"2013","journal-title":"J Infect Dis"},{"issue":"19","key":"zoi241678r11","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1056\/NEJMoa2215254","article-title":"Decolonization in nursing homes to prevent infection and hospitalization.","volume":"389","author":"Miller","year":"2023","journal-title":"N Engl J Med"},{"issue":"10177","key":"zoi241678r12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/S0140-6736(18)32593-5","article-title":"Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial.","volume":"393","author":"Huang","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"zoi241678r13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1056\/NEJMoa1716771","article-title":"Decolonization to reduce postdischarge infection risk among MRSA carriers.","volume":"380","author":"Huang","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi241678r14","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.2337\/dc05-2031","article-title":"Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study.","volume":"29","author":"Boyko","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"zoi241678r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0094-1298(02)00070-6","article-title":"Acute wound healing: an overview.","volume":"30","author":"Monaco","year":"2003","journal-title":"Clin Plast Surg"},{"issue":"12","key":"zoi241678r16","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections.","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi241678r19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/cid\/ciaa1103","article-title":"Assessing the potential for unintended microbial consequences of routine chlorhexidine bathing for prevention of healthcare-associated infections.","volume":"72","author":"Babiker","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"11","key":"zoi241678r20","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1128\/JCM.01444-16","article-title":"Chlorhexidine and mupirocin susceptibility of methicillin-resistant Staphylococcus aureus isolates in the REDUCE-MRSA trial.","volume":"54","author":"Hayden","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"9","key":"zoi241678r21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1086\/667371","article-title":"Relationship between chlorhexidine gluconate skin concentration and microbial density on the skin of critically ill patients bathed daily with chlorhexidine gluconate.","volume":"33","author":"Popovich","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"zoi241678r2","author":"Margolis"},{"key":"zoi241678r17","volume-title":"Sample Size Tables for Clinical Studies","author":"Machin","year":"1997","edition":"2nd ed"},{"key":"zoi241678r1","unstructured":"Centers for Disease Control and Prevention. National diabetes statistics report 2020: estimates of diabetes and its burden in the United States. February 14, 2020. Accessed April 1, 2024. https:\/\/stacks.cdc.gov\/view\/cdc\/85309\/cdc_85309_DS1.pdf"},{"key":"zoi241678r18","unstructured":"National Center for Farmworker Health, Centers for Disease Control and Prevention. Take charge of your diabetes: healthy feet. Accessed March 18, 2024. https:\/\/www.ncfh.org\/uploads\/3\/8\/6\/8\/38685499\/diabetes-feet__eng.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2830347\/lydecker_2025_oi_241678_1741278690.35435.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T11:11:00Z","timestamp":1741691460000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2830347"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.60087","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}